Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sherry

Showing results (201-210 of 252) with videos related to

Pageof 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2019
T-Cell Receptor Gene Therapy for Human Papillomavirus-Associated Epithelial Cancers: A First-in-Human, Phase I/II StudyStacey L Doran, Sanja Stevanović, Sabina Adhikary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
Persistence of CTL clones targeting melanocyte differentiation antigens was insufficient to mediate significant melanoma regression in humansSmita S Chandran, Biman C Paria, Abhishek K Srivastava, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 27, 2022
Selective Ablation of <i>Sod2</i> in Astrocytes Induces Sex-Specific Effects on Cognitive Function, d-Serine Availability, and AstrogliosisMatthew P Baier, Raghavendra Y Nagaraja, Hannah P Yarbrough, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 27, 2006
Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanomaAjay V Maker, James C Yang, Richard M Sherry, et al.
Annals of Surgical Oncology|November 12, 2005
Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II studyAjay V Maker, Giao Q Phan, Peter Attia, et al.
Human Gene Therapy|June 14, 2003
Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigenSteven A Rosenberg, James C Yang, Richard M Sherry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2003
Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancerJames C Yang, Richard M Sherry, Seth M Steinberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2015
Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cellsSanja Stevanović, Lindsey M Draper, Michelle M Langhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccinesFranz O Smith, Stephanie G Downey, Jacob A Klapper, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 15, 2006
Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccinesSteven A Rosenberg, Richard M Sherry, Kathleen E Morton, et al.
Pageof 26

Showing results (201-210 of 252) with videos related to

Sort By:
Pageof 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2019
T-Cell Receptor Gene Therapy for Human Papillomavirus-Associated Epithelial Cancers: A First-in-Human, Phase I/II StudyStacey L Doran, Sanja Stevanović, Sabina Adhikary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
Persistence of CTL clones targeting melanocyte differentiation antigens was insufficient to mediate significant melanoma regression in humansSmita S Chandran, Biman C Paria, Abhishek K Srivastava, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 27, 2022
Selective Ablation of <i>Sod2</i> in Astrocytes Induces Sex-Specific Effects on Cognitive Function, d-Serine Availability, and AstrogliosisMatthew P Baier, Raghavendra Y Nagaraja, Hannah P Yarbrough, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 27, 2006
Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanomaAjay V Maker, James C Yang, Richard M Sherry, et al.
Annals of Surgical Oncology|November 12, 2005
Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II studyAjay V Maker, Giao Q Phan, Peter Attia, et al.
Human Gene Therapy|June 14, 2003
Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigenSteven A Rosenberg, James C Yang, Richard M Sherry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2003
Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancerJames C Yang, Richard M Sherry, Seth M Steinberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2015
Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cellsSanja Stevanović, Lindsey M Draper, Michelle M Langhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccinesFranz O Smith, Stephanie G Downey, Jacob A Klapper, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 15, 2006
Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccinesSteven A Rosenberg, Richard M Sherry, Kathleen E Morton, et al.
Pageof 26